Predicine is a leading biotechnology company based in Schaumburg, IL, specializing in advancing precision medicine through their next-generation liquid biopsy platform. Their innovative technology enables molecular insights into cancer from blood or urine, allowing for more accurate and personalized treatment options.
With a focus on molecular profiling and clinical trials, Predicine offers a range of solutions such as PredicineATLAS, PredicineCARE, PredicineRNA, and PredicineHEME, which provide comprehensive genomic data and analysis to accelerate oncology drug development. Their proprietary GeneRADAR platform allows for simultaneous profiling of DNA and RNA, providing in-depth insights into cancer biology. Predicine's collaborations with leading biopharmaceutical companies and their commitment to precision oncology make them a key player in the field of liquid biopsy and precision medicine.
Generated from the website